Biology Reference
In-Depth Information
Rottmann, M., McNamara, C.,Yeung, B.K., Lee, M.C., Zou, B., Russell, B., Seitz, P., Plouffe,
D.M., Dharia, N.V., Tan, J., Cohen, S.B., Spencer, K.R., González-Páez, G.E., Lakshmi-
narayana, S.B., Goh, A., Suwanarusk, R., Jegla, T., Schmitt, E.K., Beck, H.-P., Brun, R.,
Nosten, F., Renia, L., Dartois,V., Keller, T.H., Fidock, D.A., Winzeler, E.A., Diagana, T.T.,
2010. Spiroindolones, a potent compound class for the treatment of malaria. Science
329, 1175-1180.
Roy Chowdhury, A., Bakshi, R., Wang, J., Yildirir, G., Liu, B., Pappas-Brown, V., Tolun, G.,
Griffith, J.D., Shapiro, T.A., Jensen, R.E., Englund, P.T., 2010. The killing of African try-
panosomes by ethidium bromide. PLoS Pathog. 6.
Salazar, E., Bank, E.M., Ramsey, N., Hess, K.C., Deitsch, K.W., Levin, L.R., Buck, J., 2012.
Characterization of
Plasmodium falciparum
adenylyl cyclase-β and its role in erythrocytic
stage parasites. PLoS One 7.
Sams-Dodd, F., 2005. Target-based drug discovery: is something wrong?. Drug Discov. Today
10, 139-147.
Savai, R., Pullamsetti, S.S., Banat, G.A., Weissmann, N., Ghofrani, H.A., Grimminger, F.,
Schermuly, R.T., 2010. Targeting cancer with phosphodiesterase inhibitors. Expert
Opin. Investig. Drugs 19, 117-131.
Schorer, M., Debache, K., Barna, F., Monney, T., Müller, J., Boykin, D.B., Stephens, C.E.,
Hemphill, A., 2012. Di-cationic arylimidamides act against
Neospora caninum
tachyzoites
by interference in membrane structure and nucleolar integrity and are active against
challenge infection in mice. Int. J. Parasitol. Drugs Drug Res. 2, 109-112.
Seebeck, T., Sterk, G.J., Ke, H., 2011. Phosphodiesterase inhibitors as a new generation
of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved
between host and parasite. Future Med. Chem. 3, 1289-1306.
Seib, K.L., Dougan, G., Rappuoli, R., 2009. The key role of genomics in modern vaccine and
drug design for emerging infectious diseases. PLoS Genet. 5.
Shapiro, T.A., Englund, P.T., 1990. Selective cleavage of kinetoplast DNA minicircles pro-
moted by antitrypanosomal drugs. Proc. Natl. Acad. Sci. U.S.A. 87, 950-954.
Sidler, D., Brockmann, A., Müller, J., Nachbur, U., Corazza, N., Renzulli, P., Hemphill, A.,
Brunner, T., 2012. Thiazolide-induced apoptosis in colorectal cancer cells is mediated
via the Jun kinase-Bim axis and reveals glutathione-S-transferase P1 as Achilles' heel.
Oncogene. 31, 4095-4106.
Singh, S.B., Zink, D.L., Liesch, J.M., Mosley, R.T., Dombrowski, A.W., Bills, G.F., Darkin-
Rattray, S.J., Schmatz, D.M., Goetz, M.A., 2002. Structure and chemistry of apicidins, a
class of novel cyclic tetrapeptides without a terminal alpha-keto epoxide as inhibitors
of histone deacetylase with potent antiprotozoal activities. J. Org. Chem. 67, 815-825.
Sisson, G., Goodwin, A., Raudonikiene, A., Hughes, N.J., Mukhopadhyay, A.K., Berg,
D.E., Hoffman, P.S., 2002. Enzymes associated with reductive activation and action of
nitazoxanide, nitrofurans, and metronidazole in
Helicobacter pylori
. Antimicrob. Agents
Chemother. 46, 2116-2123.
Slavic, K., Krishna, S., Derbyshire, E.T., Staines, H.M., 2011. Plasmodial sugar transporters as
anti-malarial drug targets and comparisons with other protozoa. Malar. J. 10, 165.
Smith, A.T., Livingston, M.R., Mai, A., Filetici, P., Queener, S.F., Sullivan, W.J.J., 2007. Quin-
oline derivative MC1626, a putative GCN5 histone acetyltransferase (HAT) inhibitor,
exhibits HAT-independent activity against
Toxoplasma gondii
. Antimicrob. Agents Che-
mother. 51, 1109-1111.
Soeiro, M.N., de Castro, S.L., de Souza, E.M., Batista, D.G., Silva, C.F., Boykin, D.W., 2008. Diami-
dine activity against trypanosomes: the state of the art. Curr. Mol. Pharmacol. 1, 151-161.
Soeiro, M.N., De Souza, E.M., Stephens, C.E., Boykin, D.W., 2005. Aromatic diamidines as
antiparasitic agents. Expert Opin. Investig. Drugs 14, 957-972.
Sousa, M.C., Poiares-da-Silva, J., 2001. The cytotoxic effects of ciprofloxacin in
Giardia lam-
blia
trophozoites. Toxicol. In Vitro 15, 297-301.
Search WWH ::
Custom Search